CAI
Price
$17.06
Change
+$0.07 (+0.41%)
Updated
Jul 13 closing price
Capitalization
4.82B
35 days until earnings call
Intraday BUY SELL Signals
VTGN
Price
$0.25
Change
-$0.01 (-3.85%)
Updated
Jul 13 closing price
Capitalization
10.37M
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CAI vs VTGN

CAI vs VTGN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CAI vs. VTGN commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAI is a Hold and VTGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (CAI: $17.06 vs. VTGN: $0.25)
Brand notoriety: CAI and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CAI: 92% vs. VTGN: 57%
Market capitalization -- CAI: $4.82B vs. VTGN: $10.37M
CAI [@Biotechnology] is valued at $4.82B. VTGN’s [@Biotechnology] market capitalization is $10.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAI’s FA Score shows that 1 FA rating(s) are green whileVTGN’s FA Score has 1 green FA rating(s).

  • CAI’s FA Score: 1 green, 4 red.
  • VTGN’s FA Score: 1 green, 4 red.
According to our system of comparison, both CAI and VTGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAI’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • CAI’s TA Score: 4 bullish, 5 bearish.
  • VTGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CAI is a better buy in the short-term than VTGN.

Price Growth

CAI (@Biotechnology) experienced а -4.21% price change this week, while VTGN (@Biotechnology) price change was +2.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

CAI is expected to report earnings on Aug 18, 2026.

VTGN is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAI($4.82B) has a higher market cap than VTGN($10.4M). CAI YTD gains are higher at: -36.768 vs. VTGN (-61.822). CAI has higher annual earnings (EBITDA): 111M vs. VTGN (-69.2M). CAI has more cash in the bank: 823M vs. VTGN (61.8M). VTGN has less debt than CAI: VTGN (1.43M) vs CAI (431M). CAI has higher revenues than VTGN: CAI (907M) vs VTGN (789K).
CAIVTGNCAI / VTGN
Capitalization4.82B10.4M46,375%
EBITDA111M-69.2M-160%
Gain YTD-36.768-61.82259%
P/E RatioN/AN/A-
Revenue907M789K114,956%
Total Cash823M61.8M1,332%
Total Debt431M1.43M30,203%
FUNDAMENTALS RATINGS
CAI vs VTGN: Fundamental Ratings
CAI
VTGN
OUTLOOK RATING
1..100
6099
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
7
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
7596
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
55n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAI's Valuation (1) in the Finance Or Rental Or Leasing industry is in the same range as VTGN (7) in the Biotechnology industry. This means that CAI’s stock grew similarly to VTGN’s over the last 12 months.

CAI's Profit vs Risk Rating (100) in the Finance Or Rental Or Leasing industry is in the same range as VTGN (100) in the Biotechnology industry. This means that CAI’s stock grew similarly to VTGN’s over the last 12 months.

VTGN's SMR Rating (99) in the Biotechnology industry is in the same range as CAI (100) in the Finance Or Rental Or Leasing industry. This means that VTGN’s stock grew similarly to CAI’s over the last 12 months.

CAI's Price Growth Rating (75) in the Finance Or Rental Or Leasing industry is in the same range as VTGN (96) in the Biotechnology industry. This means that CAI’s stock grew similarly to VTGN’s over the last 12 months.

CAI's P/E Growth Rating (99) in the Finance Or Rental Or Leasing industry is in the same range as VTGN (100) in the Biotechnology industry. This means that CAI’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAIVTGN
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
6%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 19 days ago
53%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 27 days ago
65%
Bearish Trend 21 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
29%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
13%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CAI
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRAK8.960.05
+0.56%
ReposiTrak
SHG72.98-0.30
-0.41%
Shinhan Financial Group Co Ltd
MOV37.84-0.69
-1.79%
Movado Group
MIR16.19-0.81
-4.76%
Mirion Technologies
CSAI0.40-0.02
-4.91%
Cloudastructure Inc

CAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAI has been loosely correlated with BMEA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CAI jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAI
1D Price
Change %
CAI100%
+0.41%
BMEA - CAI
38%
Loosely correlated
+0.76%
TECH - CAI
38%
Loosely correlated
+0.08%
RXRX - CAI
29%
Poorly correlated
-7.30%
HRMY - CAI
29%
Poorly correlated
-3.53%
VTGN - CAI
29%
Poorly correlated
-2.05%
More